Lv5
1050 积分 2026-04-07 加入
New, Novel Lipid-Lowering Agents for Reducing Cardiovascular Risk: Beyond Statins
22天前
已完结
RNA-Based Therapies for Hypercholesterolemia and Coronary Artery Disease
22天前
已完结
RNA interference for lipid disorders: is this the future?
22天前
已完结
A phase I/II study of ARO-HSD, an RNA interference therapeutic, for the treatment of non-alcoholic steatohepatitis
26天前
已完结
Somatic loss-of-function mutations in CIDEB reduce hepatic steatosis by increasing lipolysis and fatty acid oxidation
26天前
已完结
Development of a Scalable Plug-and-Play Platform for Dual-Targeting LPA and PCSK9, and Beyond, in Cardiovascular Disease Treatment
1个月前
已完结
Research advances in current drugs targeting hyperlipidemia (Review)
1个月前
已完结
Engineered exosomes loaded with M1–8 peptide for targeted therapy of hepatocellular carcinoma
1个月前
已完结
Extracellular vesicles as carriers for protein and peptide therapeutics delivery: A review
1个月前
已完结
Enhancing the Therapeutic Potential of Extracellular Vesicles Using Peptide Technology
1个月前
已完结
皖公网安备34019202002308
